0001193805-24-000801.txt : 20240614
0001193805-24-000801.hdr.sgml : 20240614
20240614160611
ACCESSION NUMBER: 0001193805-24-000801
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240612
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SASSINE ANDY
CENTRAL INDEX KEY: 0001515322
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38942
FILM NUMBER: 241044740
MAIL ADDRESS:
STREET 1: 82 DEVONSHIRE STREET
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcturus Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001768224
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8589002660
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
e663716_4-sassine.xml
X0508
4
2024-06-12
0
0001768224
Arcturus Therapeutics Holdings Inc.
ARCT
0001515322
SASSINE ANDY
C/O ARCTURUS THERAPEUTICS HOLDINGS INC.
10628 SCIENCE CENTER DRIVE, SUITE 250
SAN DIEGO
CA
92121
1
1
0
0
Chief Financial Officer
0
Common Stock
2024-06-12
4
S
0
50000
32.03
D
220526
D
The sales reported on this Form 4 were effected in open market transactions by the Reporting Person.
Reflects the weighted average price of 50,000 shares of common stock of Arcturus Therapeutics Holdings Inc. (the "Issuer") sold by the Reporting Person in multiple transactions on June 12, 2024, with sales prices ranging from $31.52 to $33.54 per share. The Reporting Person undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Ilan Katz, attorney-in-fact
2024-06-14